AGNG vs TINY: Grades, Fees and Holdings Compared

Global X Aging Population ETF

AGNGANasdaq

ProShares Nanotechnology ETF

TINYCNYSE Arca

Overlap

0.0%by weight

Expense ratio

AGNG −0.08pt a year

AGNG0.50%TINY0.58%

Avg volume · 30D

TINY 1.1×the volume

AGNG10.4KTINY11.8K

5Y return · a year

TINY +3.5pt

AGNG+6.8%TINY+10.3%

AGNG vs TINY Performance

Oct 29, 2021 – Oct 30, 2026

+38.7%AGNG+63.0%TINY

Expense ratio: AGNG 0.50%, better; TINY 0.58%
Fund size: AGNG $96M; TINY $12M
1Y total return: AGNG +18.0%; TINY +23.3%, better
Yield (12M): AGNG 0.83%, better; TINY 0.10%
Holdings: AGNG 87; TINY 31
Avg volume (30D): AGNG 10.4K sh; TINY 11.8K sh, better
NAV per share: AGNG $39.56; TINY $66.40
52W range

ETF.net Grade

Pillar letters and Scores for AGNG, TINY, with each pillar’s weight
Pillar	AGNG	TINY
Cost30% weight	B67Higher	C53
Mission25% weight	Not scored	B56
Risk15% weight	A80Higher	D32
Tradability15% weight	B63Higher	C45
Holdings10% weight	A76	Not scored
Durability5% weight	A74Higher	B58

Rank among Global Thematic funds

How we build Categories ›

Same Category. AGNG and TINY are both graded against the same 18 Global Thematic funds, so their Grades compare head to head.

Global Thematic⁠

Category · 18 funds

See all 18 ›

AGNG ranks 2nd and TINY 9th of 18 funds in the Global Thematic Category.

Rank 1AFITEState Street SPDR S&P Kensho Future Security ETFScore 79
Rank 2AAGNGGlobal X Aging Population ETFScore 70
Rank 3BWRNDNYLI Global Equity R&D Leaders ETFScore 69
Rank 9CPWRDTCW Transform Systems ETFScore 46
Rank 9CTINYProShares Nanotechnology ETFScore 46
Rank 11CPRNTThe 3D Printing ETFScore 42

Our read on each fund

ETF.net Research

AGNGAGlobal X Aging Population ETF

TINYCProShares Nanotechnology ETF

In short

AGNG AGNG plays the one trend nobody needs a crystal ball for: people getting older. About 80 developed-market names in medical devices, pharma and senior living, wrapped around an aging-population index, for 0.50% a year.

TINY Nanotechnology is a theme most fund shelves skip entirely. TINY is ProShares' answer: roughly 30 global companies working at the nanoscale, bundled through one Solactive index into a single ticker.

Stated mandate

AGNG The Fund seeks to track, before fees and expenses, the price and yield performance of the Indxx Aging Population Thematic Index.

TINY TINY invests in companies whose business operations are in nanotechnology, providing exposure to the emerging nanotechnology theme through a global portfolio.

Why people hold it

AGNG One ticket on the demographics trade: roughly 80 developed-market companies tied to older consumers, tracking the Indxx Aging Population Thematic Index.globalxetfs.com
0.50% a year, below the median fee in its global thematic peer group. Niche themes usually charge a premium for the privilege.
Running since 2016, so the theme has a long live record rather than a backtest and a pitch deck.
Portfolio construction and risk profile put it among the stronger builds in its global thematic peer group.

TINY Pure-play access to a theme most shelves skip. It tracks the Solactive Nanotechnology Index, built from companies whose business operations sit in nanotechnology.proshares.com
About 30 global holdings, so the theme actually drives the fund instead of sitting as a rounding error inside a broad tech portfolio.
0.58% a year puts it in line with the typical global thematic ETF, even though the mandate is far narrower than most.
ProShares has run it since 2021, it pays quarterly, and it stands in the upper half of its global thematic peer group.

Worth knowing

AGNG Thinly traded, so spreads can run wider than in mega-cap funds and how you place the order matters more.
One theme, tilted to healthcare and developed markets, so its path can look nothing like a broad global index.
Distributions arrive annually or semiannually, not monthly, and the asset base is modest by ETF standards.

TINY Small and thinly traded, which usually means wider bid-ask spreads and more price impact than a mainstream index fund.
About 30 stocks in one emerging theme is a concentrated ride, and it can swing harder than a diversified technology fund.
Broader thematic funds charge less (KLMT at 0.10%, IQSZ at 0.19%), though neither aims at nanotechnology.

Full AGNG profile⁠

Full TINY profile⁠

AGNG vs TINY Holdings

As of Oct 13, 2026

How AGNG and TINY differ

Overlap by weight

0.0%

Shared holdings make up 0.0% of AGNG and 0.0% of TINY.

Level by level

Holdings0 in both0.0%
Sector6 Sectors10.7%
Countryby domicile66.0%
Asset classEquity100%

Sector

Sector weights in AGNG and TINY, widest gap first
Sector	More in AGNGMore in TINY	AGNG	TINY
Health Care	AGNG +80.4 points	91.1%	10.7%
Technology	TINY +71.9 points	0.0%	71.9%
Real Estate	AGNG +8.9 points	8.9%	0.0%
Materials	TINY +8.2 points	0.0%	8.2%
Consumer Discretionary	TINY +5.1 points	0.0%	5.1%
Industrials	TINY +4.2 points	0.0%	4.2%

Country, concentration and asset class

Country by domicile

Country weights in AGNG and TINY, widest gap first
Country	More in AGNGMore in TINY	AGNG	TINY
Japan	TINY +15.9 points	5.6%	21.5%
Switzerland	AGNG +11.5 points	11.5%	0.0%
Denmark	AGNG +6.3 points	6.3%	0.0%
United States	AGNG +6.0 points	61.5%	55.5%
Netherlands	TINY +5.6 points	0.0%	5.6%
Taiwan	TINY +5.2 points	0.0%	5.2%
South Korea	TINY +4.9 points	2.2%	7.1%
United Kingdom	AGNG +3.2 points	3.2%	0.0%
Other countries (10)	AGNG +4.7 points	9.8%	5.1%

Outside the US: AGNG 86% developed, 14% emerging. TINY 67% developed, 33% emerging.

Concentration

Weight in the 10 largest Holdings

AGNG33.9%
TINY54.2%

Securities held

AGNG84
TINY30

Asset class

AGNG: Equity
TINY: Equity

Holdings

Only in AGNG84
In both0
Only in TINY30

Only in AGNG

84 securities, 100% of AGNG by weight

AbbVie Inc3.95%
Eli Lilly & Co3.69%
Merck & Co. Inc.3.54%
Amgen Inc3.50%
Welltower Inc3.33%
Johnson & Johnson3.26%
Edwards Lifesciences Corp3.25%
Roche Holding Ag-Br3.19%
Medtronic PLC3.12%
Novo Nordisk A/S-B3.07%
Regeneron Pharmaceuticals2.96%
Ventas Inc2.93%
Bristol-Myers Squibb Co2.89%
Beone Medicines Ltd-Adr2.62%
Sandoz Group AG2.56%
Stryker Corp2.48%
Astrazeneca PLC2.30%
Dexcom Inc2.26%
Celltrion Inc2.24%
Alcon Inc2.18%
Ucb SA2.14%
Boston Scientific Corp2.13%
Chugai Pharmaceutical Co Ltd2.05%
Astellas Pharma Inc1.75%
Hansoh Pharmaceutical Group1.66%
United Therapeutics Corp1.65%
Genmab A/S1.63%
Incyte Corp1.51%
Terumo Corp1.46%
Sonova Holding Ag-Reg1.31%
Zimmer Biomet Holdings Inc1.23%
Straumann Holding Ag-Reg1.20%
Exelixis Inc1.06%
Neurocrine Biosciences Inc0.97%
Omega Healthcare Investors0.91%
Halozyme Therapeutics Inc0.90%
Fresenius Medical Care AG0.85%
Davita Inc0.83%
Smith & Nephew PLC0.80%
Demant A/S0.77%
Ensign Group Inc/The0.69%
Insulet Corp0.67%
Glaukos Corp0.67%
Integer Holdings Corp0.44%
Ypsomed Holding Ag-Reg0.40%
Cochlear Ltd0.40%
Novocure Ltd0.40%
Merit Medical Systems Inc0.39%
Aedifica0.39%
Amplifon Spa0.39%

Only in TINY

30 securities, 99.7% of TINY by weight

Bruker Corp8.02%
Screen Holdings Co Ltd5.59%
Asml Holding NV5.55%
Taiwan Semiconductor Manufac5.37%
Nikon Corp5.09%
Entegris Inc5.08%
NVIDIA Corp5.05%
Cabot Corp4.98%
Applied Materials Inc4.81%
Jgc Holdings Corp4.69%
Lam Research Corp4.59%
Jeol Ltd4.25%
Qnity Electronics Inc4.15%
Veeco Instruments Inc3.86%
Axcelis Technologies Inc3.59%
Lg Chem Ltd3.43%
Onto Innovation Inc3.36%
Ultra Clean Holdings Inc3.08%
Nanobiotix2.85%
Nlight Inc2.52%
Shanghai Biren Technology -H2.23%
Park Systems Corp2.15%
Qd Laser Inc1.19%
Wonik Qnc Corp0.95%
Toyo Gosei Co Ltd0.85%
Nve Corp0.69%
Duksan Hi-Metal Co Ltd0.59%
Eikon Therapeutics Inc0.54%
Syntec Optics Holdings Inc0.43%
Jeio Co Ltd0.17%

Weight gaps

AGNG and TINY share no securities.

All 83 AGNG holdings⁠All 32 TINY holdings⁠

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

AGNG vs TINY Cost

Overpaying TINY vs AGNG

$1,474

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

AGNG 0.50%
$9,979
TINY 0.58%
$11,453

Amount$10,000

Years30 years

Cost over time

AGNG 0.50%
TINY 0.58%
Overpaying

Year by year

Year	AGNG	TINY	Overpaying
10	$900	$1,041	$141
20	$3,460	$3,986	$526
30	$9,979	$11,453	$1,474

Expense ratio

0.50%AGNG, cheaper
0.58%TINY

AGNG0.50%TINY0.58%

0.18%0.90%

Middle half of Global Thematic funds
Median 0.58%

AGNG 7th cheapest of 18 funds

TINY 9th cheapest of 18 funds

AGNG vs TINY Dividends

Last 12 months to Oct 30, 2026

Yield (12M): AGNG 0.83%, better; TINY 0.10%
Payout (12M): AGNG $0.33; TINY $0.07
Last payment: AGNG $0.16; TINY $0.0083
Ex-dividend: AGNG Jun 29, 2026; TINY Jun 24, 2026
Paid on: AGNG Jul 7, 2026; TINY Jun 30, 2026
Frequency: AGNG Twice a year; TINY Twice a year

Distribution history

Per share, 2017 to 2026, same scale for both

AGNGTwice a year · 17 paymentsAll AGNG payments⁠

TINYTwice a year · 12 paymentsAll TINY payments⁠

AGNG vs TINY Risk

Fall from peak · 5 years

AGNG
TINY

Risk facts

VolatilityStd dev, 3 years: AGNG 13.1%, betterTINY 34.6%
Return per unit of riskSharpe ratio, 3 years: AGNG 0.98, betterTINY 0.74
Worst fallMax drawdown, 5 years: AGNG −23.9%, betterTINY −43.8%
Market sensitivityBeta, 5 years: AGNG 0.60TINY 1.89; Market = 1

Popular comparisons

AGNGAvsFITEA
Global X Aging Population ETF · State Street SPDR S&P Kensho Future Security ETF
Expense ratio
0.50% · 0.45%
Category
TINYCvsFITEA
ProShares Nanotechnology ETF · State Street SPDR S&P Kensho Future Security ETF
Expense ratio
0.58% · 0.45%
Category
AGNGAvsWRNDB
Global X Aging Population ETF · NYLI Global Equity R&D Leaders ETF
Expense ratio
0.50% · 0.18%
Category
TINYCvsWRNDB
ProShares Nanotechnology ETF · NYLI Global Equity R&D Leaders ETF
Expense ratio
0.58% · 0.18%
Category
AGNGAvsICOPB
Global X Aging Population ETF · iShares Copper and Metals Mining ETF
Expense ratio
0.50% · 0.47%
Category
TINYCvsICOPB
ProShares Nanotechnology ETF · iShares Copper and Metals Mining ETF
Expense ratio
0.58% · 0.47%
Category